These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 8691133)

  • 1. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.
    Groux H; Bigler M; de Vries JE; Roncarolo MG
    J Exp Med; 1996 Jul; 184(1):19-29. PubMed ID: 8691133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique cytokine production profile of anergic human T cells in SCID-hu mice after staphylococcal enterotoxin B administration.
    Schols D; Jones D; Roncarolo MG
    J Immunol; 1995 Apr; 154(7):3204-12. PubMed ID: 7534791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.
    Takahashi T; Kuniyasu Y; Toda M; Sakaguchi N; Itoh M; Iwata M; Shimizu J; Sakaguchi S
    Int Immunol; 1998 Dec; 10(12):1969-80. PubMed ID: 9885918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not by IL-4 or IL-13.
    Fasler S; Aversa G; Terr A; Thestrup-Pedersen K; de Vries JE; Yssel H
    J Immunol; 1995 Nov; 155(9):4199-206. PubMed ID: 7594575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-2 unresponsiveness in anergic CD4+ T cells is due to defective signaling through the common gamma-chain of the IL-2 receptor.
    Grundström S; Dohlsten M; Sundstedt A
    J Immunol; 2000 Feb; 164(3):1175-84. PubMed ID: 10640728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-stimulation via CD28 induces activation of a refractory subset of MRL-lpr/lpr T lymphocytes.
    Clements JL; Winslow G; Donahue C; Cooper SM; Allison JP; Budd RC
    Int Immunol; 1993 Nov; 5(11):1451-60. PubMed ID: 7903158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of responsiveness in superantigen-induced anergic T cells. Role of ligand density and costimulatory signals.
    Heeg K; Wagner H
    J Immunol; 1995 Jul; 155(1):83-92. PubMed ID: 7602125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression.
    Koenen HJ; Fasse E; Joosten I
    J Immunol; 2003 Dec; 171(12):6431-41. PubMed ID: 14662842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The avidity spectrum of T cell receptor interactions accounts for T cell anergy in a double transgenic model.
    Girgis L; Davis MM; Fazekas de St Groth B
    J Exp Med; 1999 Jan; 189(2):265-78. PubMed ID: 9892609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal anergy is maintained independently of T cell proliferation.
    Colombetti S; Benigni F; Basso V; Mondino A
    J Immunol; 2002 Dec; 169(11):6178-86. PubMed ID: 12444122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early growth response gene-2, a zinc-finger transcription factor, is required for full induction of clonal anergy in CD4+ T cells.
    Harris JE; Bishop KD; Phillips NE; Mordes JP; Greiner DL; Rossini AA; Czech MP
    J Immunol; 2004 Dec; 173(12):7331-8. PubMed ID: 15585857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4(+)CD25(+) T cells facilitate the induction of T cell anergy.
    Ermann J; Szanya V; Ford GS; Paragas V; Fathman CG; Lejon K
    J Immunol; 2001 Oct; 167(8):4271-5. PubMed ID: 11591749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligation of the V7 molecule on T cells blocks anergy induction through a CD28-independent mechanism.
    Soares LR; Rivas A; Tsavaler L; Engleman EG
    J Immunol; 1997 Aug; 159(3):1115-24. PubMed ID: 9233604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anergic T cells generated in vitro suppress rejection response to islet allografts.
    Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
    Transplantation; 2000 May; 69(10):2144-8. PubMed ID: 10852614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single human T cells stimulated in the absence of feeder cells transcribe interleukin-2 and undergo long-term clonal growth in response to defined monoclonal antibodies and cytokine stimulation.
    Sunder-Plassmann R; Breiteneder H; Zimmermann K; Strunk D; Majdic O; Knapp W; Holter W
    Blood; 1996 Jun; 87(12):5179-84. PubMed ID: 8652831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD3-induced anergy in cloned human Th0, Th1, and Th2 cells.
    Nguyen DD; Beck L; Spiegelberg HL
    Cell Immunol; 1995 Oct; 165(1):153-7. PubMed ID: 7671320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
    Damle NK; Leytze G; Klussman K; Ledbetter JA
    Eur J Immunol; 1993 Jul; 23(7):1513-22. PubMed ID: 8100773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin (IL) 4, in the absence of antigen stimulation, induces an anergy-like state in differentiated CD8+ TC1 cells: loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines.
    Sad S; Mosmann TR
    J Exp Med; 1995 Nov; 182(5):1505-15. PubMed ID: 7595220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell effector function and anergy avoidance are quantitatively linked to cell division.
    Wells AD; Walsh MC; Sankaran D; Turka LA
    J Immunol; 2000 Sep; 165(5):2432-43. PubMed ID: 10946268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.